IRIS
ZERBI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.758
EU - Europa 1.469
AS - Asia 330
AF - Africa 238
SA - Sud America 18
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.696
FI - Finlandia 408
IE - Irlanda 339
NG - Nigeria 235
CN - Cina 211
FR - Francia 154
DE - Germania 141
IT - Italia 112
NL - Olanda 93
SE - Svezia 91
CA - Canada 61
GB - Regno Unito 56
TR - Turchia 48
BE - Belgio 32
IL - Israele 24
IN - India 13
AU - Australia 10
IR - Iran 9
CH - Svizzera 8
CL - Cile 8
RU - Federazione Russa 8
AR - Argentina 7
SG - Singapore 7
UA - Ucraina 7
JP - Giappone 6
RO - Romania 6
HK - Hong Kong 5
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
EU - Europa 3
BD - Bangladesh 2
BR - Brasile 2
ES - Italia 2
GH - Ghana 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
MN - Mongolia 1
PA - Panama 1
PH - Filippine 1
Totale 9.831
Salva come PNG Salva come JPEG
Città #
Wilmington 1.612
Chandler 1.510
San Mateo 582
Ann Arbor 482
Helsinki 408
Dublin 339
Leawood 308
Lawrence 275
Princeton 275
Boardman 238
Benin City 235
Shanghai 206
New York 184
Woodbridge 155
Paris 153
Ashburn 149
Fairfield 132
Amsterdam 91
Toronto 60
Seattle 53
San Diego 50
London 49
Kocaeli 39
Milan 37
Norwalk 36
Brussels 32
Abbiategrasso 24
Monmouth Junction 19
Falkenstein 16
Redmond 14
Redwood City 14
Santa Clara 14
Washington 12
Phoenix 11
Los Angeles 10
Pune 10
Des Moines 9
Malatya 8
Cambridge 7
Hanover 6
Andover 5
Berlin 5
Collecorvino 5
Falls Church 5
Sacramento 5
Buenos Aires 4
Moscow 4
Buffalo 3
Crema 3
Jerusalem 3
Lausanne 3
Pisa 3
Riverview 3
Auckland 2
Belgrade 2
Büdelsdorf 2
Chisinau 2
Clearwater 2
Dhaka 2
Frankfurt am Main 2
Geneva 2
Henderson 2
Kumasi 2
Lissone 2
Milwaukee 2
Newark 2
Oslo 2
Palermo 2
Rome 2
Shenyang 2
Addison 1
Adliswil 1
Atlanta 1
Augusta 1
Birmingham 1
Bogotá 1
Bologna 1
Braunschweig 1
Brno 1
Bucharest 1
Cairo 1
Central District 1
Chicago 1
Copenhagen 1
Cupertino 1
Dallas 1
Den Haag 1
Eden Prairie 1
Fukuoka 1
Genoa 1
Gunzenhausen 1
Hamm 1
Heimberg 1
Houston 1
Istanbul 1
Jacksonville 1
Kemerovo 1
Knoxville 1
Las Vegas 1
Livingston 1
Totale 7.979
Salva come PNG Salva come JPEG
Nome #
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 60
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 58
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 56
An uncommon cause of massive intraperitoneal bleeding: leiomyoblastoma of the stomach. 54
The evolution of post-operative pancreatic fistula (POPF) classification: A single-center experience 54
Commentary to paper "Primary versus secondary delayed gastric emptying (DGE) grades B and C of the International Study Group of Pancreatic Surgery after pancreatoduodenectomy: a retrospective analysis on a group of 132 patients". 54
Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. 54
A Bone in the Pancreas 54
BEYOND PALLIATION: USING EUS-GUIDED CHOLEDOCHODUODENOSTOMY WITH A LUMEN-APPOSING METAL STENT AS A BRIDGE TO SURGERY 53
Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer 53
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice? 53
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 53
Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms 53
CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer 52
AN ONCOCYTIC CARCINOMA OF THE PANCREAS WITH PULMONARY AND SUBCUTANEOUS METASTASES 52
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 52
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. 52
Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer 52
Final results of a prospective trial of a PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma 51
Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study - ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II 51
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy 51
Prognostic value of the immune-related transcriptome in biliary tract cancers 51
Diagnosis and treatment of acute pancreatitis: The position statement of the Italian Association for the study of the pancreas 50
Effect of Surgeon Volume on Outcome Following Pancreaticoduodenectomy in a High-Volume Hospital 50
Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: A comparison with dynamic CT and angiography 50
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma 50
Pancreatic enzyme replacement therapy in post-pancreatectomy patients. 49
Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controoled trial 49
Assessment of Perioperative Body Composition at Bioimpedance Vector Analysis (BIVA) Predicts Morbidity Following Pancreatic Resection for Cancer 49
Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer 49
Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy 49
Characterisation of the immune-related transcriptome in resected biliary tract cancers 49
Morphohistological Features of Pancreatic Stump Are the Main Determinant of Pancreatic Fistula after Pancreatoduodenectomy 48
Management and Outcomes of Pancreatic Resections Performed in High-Volume Referral and Low-Volume Community Hospitals Lead by Surgeons Who Shared the Same Mentor: The Importance of Training 48
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile 48
Application of minimally invasive pancreatic surgery: an Italian survey 48
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors 48
Enhanced Recovery After Pancreatic Surgery Does One Size Really Fit All? A Clinical Score to Predict the Failure of an Enhanced Recovery Protocol After Pancreaticoduodenectomy 48
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 47
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 47
RELIABILITY OF PANCREATIC-CANCER STAGING CLASSIFICATIONS 47
Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers 47
Diagnosi e terapia degli insulinomi: esperienza in 28 casi 46
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways. 46
A prospective multicentre survey on the treatment of acute pancreatitis in Italy 46
Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity 46
INTRAOPERATIVE RADIATION-THERAPY ADJUVANT TO RESECTION IN THE TREATMENT OF PANCREATIC-CANCER 46
A cost-benefit analysis of surgical approach to pancreatic cancer 46
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 46
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 45
Different reconstruction techniques after pancreatoduodenectomy do not affect clinical and patient reported outcomes. 45
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: A dose-finding study 45
Pancreatic metastases: An increasing clinical entity. 44
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel 44
Pylorus-preserving pancreatoduodenectomy 44
Preparazione del paziente e vie d'accesso 44
Beyond Palliation: Using EUS-Guided Choledochoduodenostomy with a Lumen-Apposing Metal Stent as a Bridge to Surgery. A Case Series 43
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 43
Parenchyma-sparing surgery for pancreatic endocrine tumors. 43
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 43
Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy 42
Role of C-Reactive Protein Assessment as Early Predictor of Surgical Site Infections Development after Pancreaticoduodenectomy 42
Evaluation of UICC TNM classification for pancreatic cancer - A study of 228 patients 42
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 42
PANCREATIC MUCINOUS CYSTIC ADENOCARCINOMA METASTASIS TO THE RECTUM 42
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. 42
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 42
[Advances and perspectives in acute pancreatitis]. FT Novita e prospettive nella pancreatite acuta. 42
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 42
Arterial vs pancreatic phase: which is the best choice in the evaluation of pancreatic endocrine tumourswith multidetector computed tomography (MDCT)? 42
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report 42
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study 42
Color Doppler imaging in the assessment of vascular involvement by pancreatic carcinoma? 41
Diagnosis of malignant change in duodenal villous adenoma. 41
Fat-absorptiom and gastroenteric pH profile in postsurgical pancreatic insufficiency: Role of the association of H2-receptor antagonists with pancreatic enzymes 41
Pylorus-preserving pancreaticoduodenectomy versus conventional whipple operation 41
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity 41
Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: magnetic resonance findings and possible diagnostic role of different nuclear medicine tests 41
Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms 41
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 41
Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods 41
A Partnership Model Between High- and Low-Volume Hospitals to Improve Results in Hepatobiliary Pancreatic Surgery 41
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis 41
[Personal experience in surgical resection of pancreatic carcinoma]. FT Esperienza personale nella chirurgia resettiva del carcinoma pancreatico. 40
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4 40
ANDROGENS USEFUL FOR DIAGNOSING PANCREATIC-CANCER 40
Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter? The FRAGERITA Study Group 40
Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study 40
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 40
Combination chemotherapy followed by chemoradiation for stage III pancreatic adenocarcinoma (PA) 40
La chirurgia pancreatica oggi 40
European evidence-based guidelines on pancreatic cystic neoplasms 40
BEHAVIOR OF TUMOR-MARKERS CA19.9, CA195, CAM43, CA242, AND TPS IN THE DIAGNOSIS AND FOLLOW-UP OF PANCREATIC-CANCER 40
Immune infiltrating cells in duodenal cancers 40
A POSTGRADUATE TEACHING COURSE IN LAPAROSCOPIC SURGERY 40
Eus-Elastography With Strain Ratio in the Diagnosis of Solid Pancreatic Lesions: A Single Center Prospective Cohort Study 39
Surgical treatment of benign and borderline neoplasms of the pancreatic body 39
What is the role of pancreas units today? 39
Le ernie diaframmatiche complicate 39
Occlusion of the pancreatic duct versus pancreaticojejunostomy - A prospective randomized trial 39
Totale 4.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/20212.928 16 41 10 14 7 933 473 220 557 370 7 280
2021/20221.376 75 14 52 334 15 12 45 217 134 112 280 86
2022/20234.071 613 164 383 442 388 346 7 311 753 357 269 38
2023/20241.587 169 210 464 90 37 211 111 197 53 33 12 0
Totale 9.976